Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 9,591 485
Selling, general and administrative (including $17,234 of stock compensation to officers, directors and employees during the year ended December 31, 2021) 47,924 6,279
Loss from Operations 57,515 6,764
Other (Income) Expense    
Interest income (38)
Interest expense 718 3,003
Change in fair value of derivative liability (211) 230
Unrealized loss on marketable securities 29
Loss on forbearance agreement 12,598
Loss on legal settlements 5,384
Amortization of debt discount 317
Total Other (Income) Expense 498 21,532
Net Loss $ (58,013) $ (28,296)
Net loss per share - basic and diluted $ (2.06) $ (6.45)
Weighted average common shares outstanding - basic and diluted 28,155,624 4,385,222